Considering the autoimmune mechanism and the expression of IL-10/TGF-β/IL-35 in EAE/MS, we speculated that Treg cell-derived IL-10/TGF-β/IL-35 have a similar inhibitory effect on DCs in EAE/MS. This evidence concerns the gene TGFB1 and myeloid sarcoma.